CCKBR and pancreatic neoplasm: IPA pathway analysis demonstrated that the pathways involved in pancreatic cancer that were downregulated by proglumide were similar to the CCK-BR-KO murine PSCs, including pathways that decrease migration, proliferation, and epithelial-to-mesenchymal transition.